Yahoo Web Search

  1. Ads

    related to: cardiovascular disease

Search results

    • Is CRISPR Therapeutics Stock a Buy?

      Is CRISPR Therapeutics Stock a Buy?

      Motley Fool via Yahoo Finance· 7 hours ago

      Though CRISPR Therapeutics' work in that indication is still in the early stages, the company has five non-Casgevy candidates in clinical trials,...